Synthetic biology is hailed as the third life science revolution following the 'DNA double helix structure' and 'genomic technology'. It is considered a new paradigm in life science research and a core driving force for transformative development in the fields of biofabrication and bioeconomy. Developing synthetic biology and the biofabrication industry highly aligns with China's major strategic needs for sustainable development, and China has intensified efforts to promote the entire chain from technology research and development to industrial layout. Many regions across the country have successively introduced relevant policies, using measures such as financial support, industrial clustering, and technological innovation to drive the synthetic biology and biofabrication industries from strategic planning to deeper development into multiple fields.
Frost & Sullivan, in collaboration with the Shanghai Synthetic Biology Industry Association, hereby release the 'White Paper on the Development of Shanghai Synthetic Biology and Biomanufacturing Industries (2025) [Abstract Edition]'. Through close cooperation and in-depth research in the areas of 'government-industry-academia-research-financing-application', the paper aims to gain insights into the current development status and needs of various entities, providing inspiration and reference for government agencies, investment institutions, industry sectors, and all sectors of society. At the same time, it explores and summarizes Shanghai's resource endowments and core competitive advantages, and through benchmarking analysis of domestic and international innovation platforms and teams, parks, and enterprises, actively explores feasible development models and paths for Shanghai in the future, promoting deep integration and healthy development of the entire industry, and then proposes strategic suggestions for industrial development.
